Market Research Report

A quick peek into the report

Brain Disease Modalities and Software Market - A Global and Regional Analysis

Focus on Product, Indication, Patient Type, End User, and Regional Analysis - Analysis and Forecast, 2022-2031

 
Some Faq's

Frequently Asked Questions

The global brain disease modalities and software market report highlights that the market was valued at $13,055.7 million in 2021 and is expected to reach $21,867.6 million by the end of 2031.

The top market players are United Imaging Healthcare Co., Ltd., Koninklijke Philips N.V., General Electric Company, Canon, Inc., Siemens Healthineers AG, Vuno Co., Ltd., Fujifilm Holdings Corporation, Aspect Imaging, IXICO, QMENTA, Cortechs.ai, Quantib, Brainomix, Qure.AI, Imaging Biometrics, LLC, A.I. Analysis, Inc.

Factors driving the growth of the brain disease modalities and software market are increasing prevalence of neurological disorders, rising AI integration in the field of medical imaging, and increasing demand for safer and non-invasive devices for medical imaging.

Some of the main challenges restricting the growth of the brain disease modalities and software market are high upfront cost of imaging devices, and declining availability of helium.

The potential opportunities that are likely to boost the growth of the brain disease modalities and software market are integration of imaging solutions with novel biomarkers to enable diagnosis of a wider range of neurological disorders, integration of 3D amplified MRI, and a new technological advancement.

Similar Product

You may also like

Published Year: 2020

Global Point-of-Care Imaging Devices Market: Focus on Product Type, Technology Type, Clinical Utilit

The Global Point-of-Care Imaging Devices Market was valued to be $8.66 billion in 2019 and is ...